Erin Hertlein
Impact in
- Genetics top 1%
- Chronic Lymphocytic Leukemia Research
-
- Lymphoma Diagnosis and Treatment
Papers in
- Genetics 24
- Chronic Lymphocytic Leukemia Research 21
- Myeloproliferative Neoplasms: Diagnosis and Treatment 3
-
- Ubiquitin and proteasome pathways 4
- Co-authors
- John C. Byrd (29 shared papers)Amy J. Johnson (10 shared papers)Xiaoli Zhang (6 shared papers)Kristie A. Blum (2 shared papers)Denis C. Guttridge (3 shared papers)Samantha Jaglowski (3 shared papers)Jeffrey J. Jones (1 shared paper)Amber Gordon (2 shared papers)
- Journals
- Blood (20 papers)Oncotarget (3 papers)Blood Advances (3 papers)Clinical Cancer Research (2 papers)Molecular and Cellular Biology (2 papers)
- Partner nations
- United StatesGermanyItaly
In The Last Decade
Erin Hertlein
44 papers receiving 1.7k citations
Erin Hertlein's Hit Papers
Peers
Comparison fields: 5 of 85
- Genetics 742
- Pathology and Forensic Medicine 456
- Immunology 508
- Hematology 248
- Cancer Research 220
Countries citing papers authored by Erin Hertlein
This map shows the geographic impact of Erin Hertlein's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Erin Hertlein with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Erin Hertlein more than expected).
Fields of papers citing papers by Erin Hertlein
This network shows the impact of papers produced by Erin Hertlein. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Erin Hertlein. The network helps show where Erin Hertlein may publish in the future.
Co-authors
The 25 scholars most cited alongside Erin Hertlein, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 48 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | Bruton tyrosine kinase represents a promising therapeutic target for treatment of chronic lymphocytic leukemia and is effectively targeted by PCI-32765 Hit paper breakdown → | 2011 | 610 |
| 2 | 2007 | 211 | |
| 3 | 2006 | 109 | |
| 4 | 2010 | 84 | |
| 5 | 2022 | 69 | |
| 6 | 2011 | 66 | |
| 7 | 2015 | 61 | |
| 8 | 2013 | 47 | |
| 9 | 2019 | 40 | |
| 10 | 2014 | 35 | |
| 11 | 2010 | 34 | |
| 12 | 2013 | 31 | |
| 13 | 2012 | 26 | |
| 14 | 2005 | 26 | |
| 15 | 2020 | 23 | |
| 16 | 2019 | 23 | |
| 17 | 2014 | 22 | |
| 18 | 2010 | 22 | |
| 19 | 2017 | 22 | |
| 20 | 2009 | 21 |
About Erin Hertlein
Erin Hertlein is a scholar working on Genetics, Molecular Biology, Immunology, Oncology and Hematology, having authored 48 papers that have together received 1.7k indexed citations. Recurring topics across this work include Chronic Lymphocytic Leukemia Research (21 papers), Acute Myeloid Leukemia Research (10 papers), Galectins and Cancer Biology (7 papers), Lymphoma Diagnosis and Treatment (7 papers), Ubiquitin and proteasome pathways (4 papers), Myeloproliferative Neoplasms: Diagnosis and Treatment (3 papers), Monoclonal and Polyclonal Antibodies Research (3 papers) and Immunodeficiency and Autoimmune Disorders (3 papers). The work is most often cited by research in Genetics (742 citations), Pathology and Forensic Medicine (456 citations), Immunology (508 citations), Hematology (248 citations) and Cancer Research (220 citations). Erin Hertlein has collaborated with scholars based in United States, Germany and Italy. Frequent co-authors include John C. Byrd, Amy J. Johnson, Xiaoli Zhang, Kristie A. Blum, Denis C. Guttridge, Samantha Jaglowski, Jeffrey J. Jones, Amber Gordon, Joseph M. Flynn and Joseph J. Buggy. Their work appears in journals such as Blood, Oncotarget, Blood Advances, Clinical Cancer Research and Molecular and Cellular Biology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.